FallsTalk Falls Prevention Program for Caregivers and Persons With Memory Loss or Dementia
NCT ID: NCT03961386
Last Updated: 2019-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2019-03-13
2020-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preliminary Clinical Trial- FallScape-D
NCT06656897
Deprescribing to Reduce Injurious Falls Among Older Adults With Dementia
NCT05777772
Telephone Support for Dementia Caregivers
NCT00735800
Fall Risk Identification and Management for Older Veterans
NCT06573983
Evaluating an In-home Multicomponent Program to Manage Concerns About Falling in Frail Community Dwelling Older People
NCT01358032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FallsTalk-C
FallsTalk CG intervention
FallsTalk-C
The FT-C experimental intervention involves two face-to-face visits including Initial and Follow-up Interviews, CG training, daily interaction with the PwD using a computer with FT-C software, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.
FallsTalk
The FallsTalk intervention involves two face-to-face visits including Initial and Follow-up Interviews,CG training, daily interaction with the PwD, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.
FallsTalk
FallsTalk intervention
FallsTalk
The FallsTalk intervention involves two face-to-face visits including Initial and Follow-up Interviews,CG training, daily interaction with the PwD, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.
PostCardOnly
Postcard only- Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FallsTalk-C
The FT-C experimental intervention involves two face-to-face visits including Initial and Follow-up Interviews, CG training, daily interaction with the PwD using a computer with FT-C software, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.
FallsTalk
The FallsTalk intervention involves two face-to-face visits including Initial and Follow-up Interviews,CG training, daily interaction with the PwD, weekly check-in calls, weekly postcard completion and monthly check-in calls for at least six months and up to one year.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* minimum age= 18
* family CG
* primary CG
* some daily personal contact with Person with Dementia (PwD) for 1 month
* basic computer skills and telephone access
* able to commit to 6 month study.
* living at home with residence in western Washington state
* minimum age= 55
* at least one fall in last 6 months or regular loss of balance
* can ambulate at least 6 feet
* ability to communicate thoughts
* willingness to participate.
Exclusion Criteria
* distance CG unable to be physically present with PwD daily for 1 month
* terminal illness with less than 6 months to live
* CG has significant memory loss.
* Residence outside of western Washington state
* Living in Residential care setting
* non-communicative
* terminal illness with less than 6 months to live
* wheel chair or bed bound.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Alzheimer's Association
OTHER
Brookside Research & Development Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Victoria Panzer, PhD
Role: PRINCIPAL_INVESTIGATOR
Brookside Research & Development
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brookside Research & Development
Freeland, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FT-Cv1.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.